Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/96104
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGatell, José M.-
dc.contributor.authorINSIGHT STALWART Study Group-
dc.date.accessioned2016-03-03T15:19:05Z-
dc.date.available2016-03-03T15:19:05Z-
dc.date.issued2010-
dc.identifier.issn1932-6203-
dc.identifier.urihttps://hdl.handle.net/2445/96104-
dc.description.abstractThe Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4+ counts compared to no therapy.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherPublic Library of Science (PLoS)-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0009334-
dc.relation.ispartofPLoS One, 2010, vol. 5, num. 2, p. e9334-
dc.relation.urihttp://dx.doi.org/10.1371/journal.pone.0009334-
dc.rightscc-by (c) Gatell, José M. et al., 2010-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationAntiretrovirals-
dc.subject.classificationVIH (Virus)-
dc.subject.otherAntiretroviral agents-
dc.subject.otherHIV (Viruses)-
dc.titleEffects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec610831-
dc.date.updated2016-03-03T15:19:10Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid20186278-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
610831.pdf344.14 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons